Reports for GLICLAZIDE

Ingredient

GLICLAZIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-21 2018-03-21 29960
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-07-30 121325
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-11-26 2020-12-17 128933
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-19 2021-03-15 134433
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-09 2023-09-22 194571
TARO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-12-03 2021-05-01 129474
MYLAN-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2018-10-29 2019-01-22 65715
MYLAN-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2021-01-20 2021-02-24 132033
TARO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-11 2019-04-15 75259

Showing 41 to 50 of 54

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
DIAMICRON 80MG TABLET Discontinued 2022-08-31 2022-10-03 168298
MYLAN-GLICLAZIDE 80MG TABLET Discontinued 2017-07-18 2017-12-02 16126
GLICLAZIDE-80 80MG TABLET Discontinued 2021-03-29 2021-03-30 136513

Showing 1 to 4 of 4